our mission:
to make life
worth living again
for millions of patients.
our mission:
to make life
worth living again
for millions of patients.
company profile
Clexio Biosciences is a clinical-stage pharmaceutical company developing novel drugs and technologies for neurological and psychiatric conditions.
Our therapies are designed to deliver clinical benefits to patients by sophisticated integration of drugs with innovative technologies.
Clexio’s pipeline is focused on the development of safe and effective treatments with rapid onset of action, to address patients’ unmet needs in Major Depressive Disorder, Parkinson’s Disease, Pain and other conditions involving impairment of the neurological system.
quick facts
Pipeline
5 drugs under development
Types of drugs
small molecules, drugs and
drug-device combinations
Indications
depression, pain and
other CNS indications
Innovation
27 patent families,
12 US granted patents.
Team
A cohesive team of
45 employees and growing.
The power of collaboration
broad network of external partners.
Our team and our partners are the
key ingredients for our success.
We believe in the power of collaboration – both internally and externally.
Our team and partners are the key ingredients in our success.